CAS number: 86401-95-8
General information about the Methylprednisolone Aceponate active pharmaceutical ingredient
Methylprednisolone Aceponate as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid, indicated in the treatment of corticosteroid-responsive dermatoses. Methylprednisolone Aceponate API is used to treat many different inflammatory conditions such as arthritis, lupus, psoriasis, ulcerative colitis, allergic disorders, gland (endocrine) disorders, and conditions that affect the skin, eyes, lungs, stomach, nervous system, or blood cells. Methylprednisolone Aceponate is also effective in the treatment of facial and scalp eczema and also for sunburn. Methylprednisolone Aceponate comes as creams, lotions, ointments.
Axplora manufactures Methylprednisolone Aceponate API
Methylprednisolone Aceponate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Methylprednisolone Aceponate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Methylprednisolone Aceponate API is commercially available as standard and micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Methylprednisolone Aceponate API.
- Therapeutic area Dermatologic
- Monograph INTERNAL SPEC.
- Regulatory documentation EU DMF
- Produced in GRO